Dose-Response: An International Journal
Volume 6 | Issue 1

Article 2

3-2008

HORMESIS [BIOLOGICAL EFFECTS OF
LOW LEVEL EXPOSURES (BELLE)] AND
DERMATOLOGY
Haw-Yueh Thong
University of California, School of Medicine, San Francisco, CA

Howard I Maibach
University of California, School of Medicine, San Francisco, CA

Follow this and additional works at: https://scholarworks.umass.edu/dose_response
Recommended Citation
Thong, Haw-Yueh and Maibach, Howard I (2008) "HORMESIS [BIOLOGICAL EFFECTS OF LOW LEVEL EXPOSURES
(BELLE)] AND DERMATOLOGY," Dose-Response: An International Journal: Vol. 6 : Iss. 1 , Article 2.
Available at: https://scholarworks.umass.edu/dose_response/vol6/iss1/2

This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

Thong and Maibach: Hormesis and dermatology

InternationalDOSE-RESPONSESociety

Dose-Response, 6:1–15, 2008
Formerly Nonlinearity in Biology, Toxicology, and Medicine
Copyright © 2008 University of Massachusetts
ISSN: 1559-3258
DOI: 10.2203/dose-response.07-029.Thong

w w w . D o s e - R e s p o n s e . o r g

HORMESIS [BIOLOGICAL EFFECTS OF LOW LEVEL EXPOSURES (BELLE)]
AND DERMATOLOGY

Haw-Yueh Thong, MD, MS, Howard I. Maibach, MD 䊐 Department of
Dermatology, University of California, School of Medicine, San Francisco, CA
䊐 Hormesis, or biological effects of low level exposures (BELLE), is characterized by
nonmonotonic dose response which is biphasic, displaying opposite effects at low and
high dose. Its occurrence has been documented across a broad range of biological models and diverse type of exposure. Since hormesis appears to be a relatively common phenomenon in many areas, the objective of this review is to explore its occurrence related to
dermatology and its public health and risk assessment implication. Hormesis appears to
be a common phenomenon in in-vitro skin biology. However, in vivo data are lacking and
the clinical relevance of hormesis has yet to be determined. Better understanding of this
phenomenon will likely lead to different strategies for risk assessment process employed
in the fields of dermatologic toxicology and pharmacology. We believe that hormesis is a
common phenomenon and should be given detailed consideration to its concept and its
risk assessment implications, and how these may be incorporated into the experimental
and regulatory processes in dermatology. The skin, with its unique characteristics, its
accessibility, and the availability of non-invasive bioengineering and DNA microarray technology, will be a good candidate to extend the biology of hormesis.

Keywords: Hormesis, biological effects of low level exposures (BELLE), biphasic dose-response relationships, dose response, dermatology, keratinocytes, melanocytes, fibroblasts, hair follicle, tumor cell
lines, toxicology, pharmacology

INTRODUCTION

Biphasic dose response, namely a low-dose stimulatory and a highdose inhibitory response, also called hormesis, or biological effects of low
level exposures (BELLE) in the field of toxicology, has been noted in a
wide range of biological model systems from immunology to cancer biology (Calabrese and Baldwin 2001, 2003; Calabrese 2005a, 2005b).
Calabrese has been the mainstay in bringing the attention of the scientific community to this interesting and a not uncommon phenomenon
(Calabrese and Baldwin 2001, 2003; Calabrese 2005a, 2005b). As noted by
Calabrese, the quantitative features of the hormetic-like biphasic dose
response were remarkably similar with respect to the amplitude of the
stimulatory response, the width of the stimulation, and the relationship
of the maximum stimulatory response to the zero equivalent point (ZEP,
i.e. threshold). Typically, the low-dose hormetic biphasic dose response
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stimulation is modest, with maximum stimulation between 30 to 60%
greater than controls, and has a rather similar appearance in different
cell types with various chemicals (Calabrese 2005b). Most stimulatory
ranges were less than 100-fold (averages 10- to 20- fold) measuring back
from the ZEP. The low-dose stimulatory response often occurs following
an initial disruption in homeostatis and appears to represent a modest
overcompensation response. It is believed that the modest stimulatory
responsiveness is due to the result of a compensatory process that “slightly” overshoots its goal of the original physiological set-point, ensuring that
the system returns to homeostasis without unnecessary and excessive
overcompensation (Calabrese 2001). Therefore, it is important to follow
the dose-response relationships overtime in order to better define its
quantitative features. While initial interest focused on the hormetic
effects of pollutants and toxic substances on biological systems (Calabrese
and Baldwin 1997), the interest expanded to include pharmacological
agents, phyto-compounds, as well as endogenous agonists (Calabrese
2005b). The hormetic- like biphasic dose response relationships appears
to be highly generalizable; that is, such responses do not appear to be
restricted by biological model, endpoint, or chemical/physical stressors
(Calabrese 2005b).
Many investigations attempted to assess mechanisms that could
account for the hormetic-like biphasic dose-response relationship. In
general, there is no single mechanism that accounts for the plethora of
hormetic relationships. Nonetheless, a common molecular tactic by
which biphasic dose-response relationships are displayed involves the
presence of two receptor subtypes affecting cell regulation, one with high
and the other with low affinity for the agonist but with notably more
capacity (i.e. more receptors) (Calabrese 2005b). Such an arrangement
may lead to the biphasic dose response, with the high-affinity receptor
activated at low concentrations, which stimulates DNA synthesis and cellular proliferation; and the low affinity/high-capacity receptor becoming
dominant at higher concentrations decreasing the cell proliferative
response. This is a general pharmacological mechanism in that it is
employed for a large number of receptor-based responses from cancer
cells to neutrophil chemotaxis and many others.
This article reviews hormetic effects of various agents on in vitro skin
biology. Recognition of this emerging biological phenomenon in dermatology should lead to markedly improved integrative assessments of animal/human skin responses to toxic substances, pharmacological agents,
as well as endogenous agonists.
EVIDENCES OF HORMESIS IN SKIN CULTURES

Skin is a complex biological model but highly approachable. Models
exist for dermatologic research which include animal vs human skin
2
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models, in vitro vs in vivo models, regional variation, stem cell biology and
hair follicle biology. Many pharmaceutical preparations in dermatology
affect cell regulation. Nonetheless, the FDA sometimes exempts dose justification for dermatologic preparations. As a result, the presence of any
hormetic effect might have been missed.
The literature in dermatology indicates that several cell types in the
skin provided evidence of hormetic-like biphasic dose/concentrationresponse relationships. A brief listing of the cell types showing hormetic
relationships and the quantitative features of dose responses is presented
in Table 1.
MELANOMA AND TUMOR CELL LINES DISPLAY HORMETIC DOSE
RESPONSES

Perhaps a more important issue regarding hormesis is its relationship
to cancer biology. The existence of hormetic dose responses in many
tumor cell lines has been noted and reviewed by Calabrese(2005b). 12
melanoma cell lines (M4Beu, B16, M24, MNT, SK-MEL, H1144, SKMEL28, Cal 1, Cal 4, Cal 23, Cal 24, Cal 32) have been shown to display
hormetic dose responses to various chemicals (guanine or guanosine
derivatives, mistletoe extract, salsolinol, tetrahydropapaveroline,
dopamine, resveratrol, thrombin and suramin) (Calabrese 2005b).
Numerous endogenous agonists, drugs, environmental contaminants,
and phytochemicals, some relevant to dermato-toxicology and dermatooncology, have also been noted to exert hormetic dose responses in various tumor cell lines (Calabrese 2005b). Examples and the proposed
mechanistic explanations are listed in Table 2.
HORMESIS AND ITS IMPLICATION IN SKIN AGING

Detailed molecular mechanisms of the hormetic effects on cell aging
are being increasingly understood. Studies have shown that repeated
mild heat stress (RMHS) has anti-aging effects on serially passaged
human fibroblasts throughout their replicative lifespan in vitro.
Treatment with RMHS at 41o C, for 1 hour twice a week, increased the levels of various chaperones and antioxidant enzymes, increased the phosphorylation-mediated activities of various stress kinases, reduced the
accumulation of oxidatively and glycoxidatively damaged proteins, stimulated proteasomal activities for the degradation of abnormal proteins,
improved cellular resistance to ethanol, hydrogen peroxide, and UV-B
rays. RMHS-treated aging human fibroblasts are also better protected
against glucose- and glyoxal-induced growth inhibition and apoptosis.
Various hormetic effects of RMHS were also noted on normal human epidermal keratinocytes, including increased replicative life span, increased
proteasomal activity, and enhanced levels of Na/K-ATPase pump. (Rattan
3
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Stimulatory responses

Sodium Lauryl Sulfate (SLS)
Cultured
SLS (10–8 to 10–5M)
keratinocytes
For 1 h: 36% stimulation
For 18h: 12% stimulation
For 4 days: ~89% stimulation
Cultured
Subconfluent fibroblast:
fibroblasts
For 1 h (10–5M): 38% stimulation
For 18h (10–6M): 32% stimulation
Confluent fibroblast for 1 h (10–8M): 40% Stimulation
SLS vs retinoic acid (RA)
Cultured
0.1-1 × 10–5 M
keratinocytes
1. For 2 h: from 4×10–4 (baseline cell acid (RA)
count) to a maximum of 8×10–4 cells
2. SLS requires a higher molar concentration
(0.75-3× 10–6 M) to achieve optimal stimulation
and the number of responding cells at optimal
concentrations is less with SLS than RA.
Cultured dermal
1. Similar stimulatory response as keratinocytes
fibroblasts
at the same doses
2. A greater fibroblast proliferative response to
optimal concentrations of RA than to optimal
concentrations of SLS.
Imidazole derivatives (econazole, clotrimazole)
Reconstructed
5-133µM (18 h contact time):
human
biphasic effect on 7-ethoxycoumarin-o-deethylase
epidermis
(ECOD) activity in the epidermis, with induction
(60- 70% increase of the basal level) at low
concentrations and inhibition (40% of the
basal level) at high concentrations

Chemicals and Cell Type

TABLE 1. Examples of Hormesis in Cultured Skin
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Table 1 continued on next page

Cotovio
et al. 1996

Varani
et al. 1991

>5×10–5 M
1. SLS has a very narrow stimulatory range and
concentrations that are slightly higher than those
that stimulate proliferation are toxic (complete
inhibition > 5×10–5 M)
2. In contrast, supra-optimal concentrations of RA are
much less toxic

>133µM

Bloom
et al. 1994

References

>10–5M

Inhibitory responses
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Ionizing radiation
Cultured human
The plating efficacy reached values significantly above
dermal fibroblasts
100% apparent survival at low doses (≥40cGy)
Corticotropin-releasing hormone
Cultured human
Biphasic effect on sebaceous lipid synthesis and
sebocytes
up-regulation on the mRNA levels of 3-β-hydroxysteroid
dehydrogenase/Δ5–4 isomerase (10–7M), but did not
affect cell viability, cell proliferation, or IL-1β-induced
IL-8 release
Arsenite
Human epidermal
Exposed to arsenite from 0.1-40µM for 1,3,5 days, cell
keratinocytes, Promyelogrowth was increased at low doses (0.5µM)
cytic leukemia cells
Arsenic trioxide (As)
Keratinocytes, MelanoExposed to for 72h:
cytes, Dendritic cells,
1. Sublethal doses of As stimulate cell proliferations.
Dermal fibroblasts,
2. As is toxic at high doses to keratinocytes, fibroblasts,
Microvascular endothelial
monocytes, and T cells; and toxic at low doses to
cells, Monocytes, T cells
melanocytes, microvascular endothelial cells and
dendritic cells.
Peak proliferation:
Keratinocytes: 30µM;
Melanocytes: 0.95µM;
Dendritic cells: 0.96µM;
Fibroblasts: 7.6µM;
Microvascular endothelial cells: 0.95µM;
Monocytes: 30µM

Chemicals and Cell Type

TABLE 1. Examples of Hormesis in Cultured Skin, continued
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LD50:
Keratinocytes: 45.5µM;
Melanocytes: 7.6µM;
Dendritic cells: 7.6µM;
Fibroblasts: 187µM;
Microvascular endothelial cells: 2.4µM;
Monocytes: 252.7µM

>1µM

≥40cGy

Inhibitory responses

Table 1 continued on next page

GrahamEvans
et al. 2003

Zhang
et al. 2003

Zouboulis
et al. 2002

Smith
et al. 1992

References
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Stimulatory responses

Inhibitory responses
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et al. 1997

Boyera

Vega
et al. 2001

Gennings
et al. 2002

References

Table 1 continued on next page

Mixture of 4 metals (Arsenic, Chromium, Cadmium, Lead)
Human
Exposed for 24h:
Synergistic cytotoxicity at total
keratinocytes
Lowest mixture dilution (0.0014× of mixtures
concentrationof 8-36µM of the metal mixture
containing the predetermined LD50 for each
(a number of mechanisms of toxicity for the
metal: As 7.7µM, Cr 4.9µM, Cd 6.1µM,
different metals may work in concert,
Pb 100µM) with a total concentration of
overwhelming growth recovery mechanisms)
0.163µM had a percent viability of 116.6%,
clearly above that observed in the singlechemical data. It is likely that this enhancement
of cell viability at the lowest mixture level is
indicative of the presence of hormesis caused
by the mixtures, rather than individual metals
Arsenite (iAsIII), Arsenate (iAsV), methylarsine oxide (MAsIIIO), complex of dimethylarsinous acid with glutathione (DMAsIIIGS), methylarsonic
acid (MAsV), dimethylarsinic acid (DMAsV)
Human
1. iAsIII and DMAsIIIGS induced an increase in cell
iAsIII : >0.5µM
keratinocytes
proliferation at low concentrations (0.001 to
iAsV : >1.0µM
0.01µM), while at high concentrations cell
DMAsIIIGS: : >0.05µM
proliferation was inhibited.
DMAsV : >0.1µM
2. pentavalent arsenicals did not stimulate cell
proliferation
3. methylated forms of AsV were more cytotoxic
than iAsV
Minoxidil
Human epidermal
0.1 to 10µM (Exposed for 5-8 days):
>1mM
and follicular
Minoxidil had biphasic effects on the proliferation
keratinocytes
and differentiation of both epidermal and
follicular keratinocytes, stimulating proliferation
at micromolar doses, while antiproliferative,
pro-differentiative and partially cytotoxic effects
were observed with millimolar concentrations

Chemicals and Cell Type

TABLE 1. Examples of Hormesis in Cultured Skin, continued
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Stimulatory responses

Inhibitory responses

Nitric oxide (NO) donors: Nitroprusside, SIN-1, DETA/NO, SNAP
Human keratinocytes,
Four different NO donors at concentrations ranging
fibroblasts
from 0.01 to 5mM were added every 12 h or 24 h, and
cells cultured for up to 3 d in the presence of these
compounds:
Keratinocytes:
1. a biphasic effect is found with increased
proliferation at low concentrations and cytostasis
at high concentrations
2. cytokeratin 6 expression is decreased at the lower
NO donor concentrations and increased at higher
concentrations as an indication of induction of
differentiation at higher NO concentrations.
Fibroblasts: Cytostasis becomes significant at ≥0.25M
of the NO donor
Antioxidants: Ascorbic-2-O- phosphate (Asc2P), Ascorbic-2-O-alpha-glucoside (Asc2G); Pro-oxidants: hydrogen peroxide (H2O2)
Human keratinocytes
Repetitive addition of Asc2P and Asc2G: cellular life-span
of keratinocytes was shown to be extended up to 150%
of population doubling levels (PDLs).
Pro-oxidants: 20 µM H2O2: extended up to 160% of PDLs,
60 µM H2O2: extended up to 120% of PDLs
The longevity of the keratinocytes was suggested to be
achieved by slowdown of age-dependent shortening of
telomeric DNA rather than by telomerase; telomeres may
suffer from less DNA lesions due to the continuous and
thorough repression of intracellular reactive oxygen species
(ROS), which was realized either by pro-vitamin C such as
Asc2P or Asc2G (with antioxidant ability more persistent than
Asc) or by 20(M H2O2 which diminished intracellular ROS
assumedly through a hormesis-like effect.

Chemicals and Cell Type

TABLE 1. Examples of Hormesis in Cultured Skin, continued
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Yokoo
et al. 2004

Krischel
et al. 1998

References
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Stimulatory responses

1,25-dihydroxy vitamin D3 (1,25(OH)2D3)
Whole organ cultures
Biphasic dose-response relationships for the effects of
of hair follicle
1,25(OH)2D3 on the total cumulative growth of hair
follicles and hair fibers.
At relatively low concentration, growth of follicles and
fibers was stimulated, to a maximal extent at 10nM of
52% and 36%.
The concentration producing 50% of the maximal
response (EC50) for both follicle and fiber growth
stimulation were 0.3nM.
The increase in cumulative growth was due to
stimulation of the initial, linear growth phases.
Ciprofloxacin (CPFX)
Human fibroblasts
The effect of CPFX on cell viability is time dependent:
1. CPFX was not cytotoxic at any concentration when
the cells were incubated for 24 hours
2. low concentrations (0.0129 and 0.032 mM) of CPFX
increased the cell survival in all incubation periods
tested.

Chemicals and Cell Type

TABLE 1. Examples of Hormesis in Cultured Skin, continued

Harmon
and Nevins
1994

Gürbay
et al. 2002

Decreased viability was observed at 0.129 and 0.194mM
(48h of exposure), and 0.129M (72 h of exposure)

References

Dose dependent and complete inhibition of follicle and
fiber growth at 100nM

Inhibitory responses
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Glabridin
Breast

Genistein
Colon, Breast, Oral

Phyto compounds
Daidzein
Breast

Progesterone
Ovarian

Estrogen
Colon, Breast

Endogenous agonists
Epidermal Growth Factor (EGF)
Ovarian, Colon, Epidermoid,
Breast

Chemicals and Tumor cell lines

Proliferation of ER+ cells was highly associated with the binding affinity of glabridin to the ER.
Optimal cell proliferation occurred at a concentration at which 1/2 of the ER sites were saturated

1. binds to the ER at estrogen binding site, the formed complex then interacts with the ERE1
thereby promoting the transcription of estrogen regulated genes
2. MCF-7 cells: cell proliferative effects were mediated through ER, while antiproliferative effect
was independent of ER.

1. Isoflavones elicit a biphasic response in the DNA synthesis and cell proliferation of the ER of
positive human breast cancer cells.
2. Effects of diadzein and biochanin A on these cells appeared to be associated with the expression
of P53.

HOSE and Oca cells: stimulation by progesterone at low concentrations, marked inhibition at high
concentrations, both blocked by specific progesterone antagonist, confirming the specificity of the
hormonal action.

Colon cancer cells: Physiological concentrations of estradiol acting via the classical ER may have a
proliferative effect. When there are high luminal concentrations of estrogenic compounds, they
may act on low affinity estrogen binding sites that mediate the growth-inhibitory effect.

A431 cells:
1. the dual effect (stimulation/inhibition) of ECF on its proliferation is associated to differential
pattern of MAP kinase activities which may involves the action of specific phosphatase(s).
2. dependent on the quantity of occupied EGF-R: a critical and restricted number of sites is
involved in EGF-growth stimulation
3. low-dose stimulation is mediated by a minority population of high-affinity EGF-Rs.

Possible mechanisms

TABLE 2. Examples of dermatology-relevant chemicals displaying hormetic dose-response relationship in tumor cell lines

Table 2 continued on next page

Tamir et al. 2000

Miodini et al. 1999;
Wang et al. 1996

Ying et al. 2002

Syed et al. 2001

Xu and Thomas
1995

Chajry et al. 1995,
1996; Dong et al.
1991; Kawamoto
et al. 1983

References
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Retinoic acid
Breast, Prostate,
Gliobastoma

Drugs
Dexamethasone
Neuroepithelial, Pancreas,
Meningiomas

Resveratrol
Breast, Leukemia

Quercetin
Breast, Oral

Chemicals and Tumor cell lines

1. Breast MCF-7 cells: via ICF-1 receptor: lowering ICF-1 levels inhibits cell proliferation.
2. Prostate LNCaP cells: possible roles of retinal-binding proteins and retinoic receptors
which may have biphasic mitogenic effects on LNCaP cells and are concentration-dependent
in affecting PSA secretion.

1. Brain tumor: Low-dose stimulation is related to the presence of glucocorticoid receptor
(probably necessary but insufficient). Inhibitory effects at high doses was believed not to be
due to receptor mediation but by other mechanisms such as cell membrane alterations.
2. Neuroepithelial cancer cells:
a. dexamethasone treatment causes glucocorticoid receptors translocation into nucleus to
modulate cell proliferation upon binding of different concentrations of dexamethasone.
Dexamethasone inhibits proliferation of some neuroepithelial cell lines, not by
glucocorticoid-induced apoptosis
b. lower concentrations of dexamethosone stimulate growth only in glucocorticoid-positive
tumors, suggested the role of the specific receptor. Higher concentrations inhibits cell
growth not due to receptor mediation, but seems to be related to other mechanisms
(cell membrane alterations)

1. MCF-7 cells: at low concentration, acts as a partial ER agonist. At high concentrations, causes
inhibition of MCF-7 cells regardless of ER status, possibly via the antagonizing of linoleic acid
(a potent stimulator of breast cancer cells)

1. similar to Genistein, a biphasic effect on cell proliferation with ER involvement.
2. regulatory over-corrections by biosynthetic control mechanisms to low levels of growth inhibiting
challenge
3. concentration-dependent antioxidant and prooxidant activities.

Possible mechanisms

TABLE 2. Examples of dermatology-relevant chemicals displaying hormetic dose-response relationship in tumor cell lines, continued

Table 2 continued on next page

Bentel et al. 1995;
Fong et al. 1993

Gibelli et al. 1989;
Kawamura et al.
1998; Paoletti
et al. 1990

Nakagawa et al. 2001

van der Woude
et al. 2003

References
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Singh et al. 1997
Dependent on the other energy sources available to epithelium: in conditions of low energy
availability, butyrate could be both stimulatory/trophic. In the presence of high levels of alternative
energy sources such as glucose, butyrate could inhibit growth/ induce apoptosis.
Sodium butyrate
Colon

Abe et al. 1999
No cytotoxicity at low concentration, but has stimulatory effects on metabolic activities particularly
in mitochondria via unknown mechanism
Toxic substances
Cadmium chloride
Ovarian

References
Possible mechanisms
Chemicals and Tumor cell lines

TABLE 2. Examples of dermatology-relevant chemicals displaying hormetic dose-response relationship in tumor cell lines, continued

Hormesis and dermatology

2004a; Rattan and Ali, 2007). While
some important issues with respect to
establishing the optimal hormetic
conditions are yet to be resolved by
future research, hormesis could be a
promising approach for modulating
aging (Rattan 2004b; Rattan 2004c).
DISCUSSION

Despite the acknowledgement of
the existence of hormesis, its importance has been disregarded by the scientific community, with one of the
reasons being the close association of
the concept of hormesis with the
highly controversial medical practice
of homeopathy (Burgdorf and
Happle 1996; Clement 1997; Cook
and Calabrese 2006).
Calabrese and Blain (2005) developed a hormesis database, containing
5600 hormetic-like dose response
relationships over approximately 900
agents from a broadly diversified spectrum of chemical classes and physical
agents, stressing the general robustness of published studies to establish
support for the hormetic doseresponse hypothesis. Table 1 showed
that clear examples of hormesis do
exist in dermatology, and Table 2 suggested that the presence of hormesis
in cancer biology may be an important phenomenon not to be overlooked.
Despite the extensive observation
of hormetic dose-response relationships for numerous agents across the
biological spectrum, most studies
assessed cellular responses. Few studies followed up in animal and human
models—normal or disease, or
assessed the simultaneous responses
of different systems to the same agent.
11
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We believe in vivo studies are necessary to provide an integrative assessment of the whole animal/human responses to various agents, to document any discrepancies between the in vitro and in vivo responses, and to
clarify the clinical implication of hormesis.
Studies on the mechanism of action and the exact definition of the
low-dose to be applied are essential to achieve a better understanding of
hormesis. Another important issue to discuss in the field of hormesis, as
proposed by van der Woude et al (2005), is the need for risk assessment
paradigms to be modified to take hormesis into account. Note that
research methods may need to be modified to take into account that using
lower doses and getting smaller responses may mean that a substantial
increase in the number of animals or test subjects may be needed to get
statistically significant results. Rietjens and Alink (2006) also suggested
that more focus should be redirect from looking only at adverse effects at
high levels of exposure to characterizing the complex biological effects,
both adverse and beneficial, at low levels of exposure. Low-dose toxicology and pharmacology will contribute to better methods for low-dose risk
assessment of chemical compounds and their effect on carcinogenesis,
taking into consideration that the ultimate biological effect of a chemical
may vary with its dose, the endpoint or target organ considered, cellular
interactions, and/or the combined exposure with other chemicals.
We believe skin is an excellent candidate to gain entrance into this
biology due to its accessibility; its complex nature, with highly differentiated cell types and various subsystems (keratinocytes, melanocytes,
Langerhans’ cells, fibroblasts, epidermis, dermis, hair follicle, eccrine,
apocrine and sebaceous units); and the availability of specialized noninvasive technology for in vivo studies (Maibach 1996; Elsner et al. 2001).
In addition, skin has been among the first organs analyzed using DNA
microarrays in various topics from skin cancers, melanomas, basal cell
carcinomas, squamous cell carcinomas, psoriasis and other inflammatory
disorders, to stem cell biology, the biology of epidermal keratinocytes,
and so forth (Table 3) (Blumenberg 2006). DNA microarray studies will
be an excellent tool to elucidate the mechanisms of hormesis in skin biology. In short, better understanding of hormesis will likely lead to different strategies for risk assessment process employed in the fields of dermatologic toxicology and pharmacology.
CONCLUSION

Hormesis is a common phenomenon in dermatology and other fields.
Detailed consideration should be given to its concept, its risk assessment
implications, and its clinical significance. However, without additional
mechanistic insight, the consequences of hormesis for risk assessment and
the possibilities for in vitro to in vivo extrapolation will remain limited.

12
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TABLE 3. Targets for DNA microarray studies in dermatology and skin biology (Blumenberg 2006)
Cell types
Keratinocyte differentiation
Melanoma and melanocytes
Epidermal stem cells and the hair cycle
Fibroblasts and other cutaneous cell types
Artificial skin substitutes
Study conditions
Wound healing and inflammatory diseases
Proinflammatory and immonumodulating cytokines in skin
Effects of UV and environmental stress
Carcinomas (basal cell carcinoma, squamous cell carcinoma)

Skin can be an excellent candidate to study hormesis and its underlying mechanisms because of its accessibility; its repertoire of inflammatory and immunomodulating cytokines, hormones, vitamins, unique
responses to ultraviolet light, toxins, and physical injury; and the availability of non-invasive bioengineering and DNA microarray technology.
Artificial skin substitutes are also available to study the effects of harmful
or dangerous agents. In essence, the skin has everything: from stem cells,
signaling and cellular differentiation, to inflammation, diseases, and cancer. All these facets could become excellent models to further study
hormesis and its clinical implications following exposure to a variety of
toxic compounds and pharmaceutical agents.
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